WHAT IS (COVID-19) THE ILLNESS THAT STARTED IN WUHAN?
It is caused by a member of the corona virus (COVID-19) family that has never been encountered before. Like other corona viruses, it has come from animals.
Many countries in the world, including China, have been terrorized by the Novel Corona-Virus infection. Several deaths have been reported. The number of victims is also several thousand. The World Health Organization (WHO) has issued this warning.
The first Corona virus was detected in Wuhan, the capital of Hubei Province, China. Later it spread to Japan, Thailand, Hong Kong, Vietnam, South Korea, Taiwan, Saudi Arabia, the United States.
The Novel Corona Virus (24-nCOV) is the seventh largest species of virus. It mainly causes respiratory infections. There are some other symptoms.
(COVID-19) SAFETY DRESS, MASK & HAND-WASHING
Liver and kidney can also be infected. Like the flu or cold, the virus spreads through coughs and coughs. But eventually there is the possibility of organ failure, organ dysfunction, pneumonia and even death.
SYMPTOMS OF CORONA VIRUS (COVID-19)
THE FOLLOWING SYMPTOMS
★ One Degree Fahrenheit Fever
★ Dry cough
★ Breathing problems
★ Stomach ache
★ Irritation in the stomach
HOW MANY PEOPLE HAVE BEEN AFFECTED?
As of 15 March, more than 182,000 people have been infected in more than 80 countries.
There have been over 7,500 deaths globally. Just over 3,000 of those deaths have occurred in mainland China. More than 79,000 people have recovered from the coronavirus.
WHAT IS THE TREATMENT OF CORONA VIRUS?
So Far, No vaccine or antidote for the corona virus has been discovered. There is no treatment for the disease.
Recently, Pharmacy Department of North South University has developed hand sanitizer to prevent corona (COVID-19) infections.
First Person In US Gets Experimental Corona Virus (COVID-19) Vaccine
A healthy volunteer in Seattle is the first person in the U.S. to receive a dose of an experimental corona Virus vaccine as part of a new clinical trial, government health officials announced today (March 16).
Over the next six weeks, researchers plan to enroll 45 participants in the trial, which will test the safety of the vaccine as well as its ability to induce an immune response in the volunteers. The trial will take place at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle.
The National Institute of Allergy and Infectious Diseases (NIAID) allowed the new vaccine to be fast-tracked into clinical trials without thorough testing in animal models, which usually stands as a strict prerequisite to human testing. While making the jump to human trials could bring the vaccine to market faster, this is only step one.
New drugs must pass through three iterative phases of clinical trials before being deemed safe and effective for widespread use. Assuming the initial tests go well, it may be 12 to 18 months before any vaccine is ready for public use, NIAID Director Dr. Anthony Fauci told the House Oversight and Reform Committee on March 12.
“Finding a safe and effective vaccine to prevent infection with SARS-CoV-2 is an urgent public health priority,” Fauci said in a NIAID statement, published March 16. “This Phase 1 study, launched in record speed, is an important first step toward achieving that goal.”
The new vaccine is a collaboration between NIAID scientists and the biotechnology company Moderna Inc., based in Cambridge, Massachusetts.
★ Avoid contact with a virus-infected person
★ Keep your hands clean and clean frequently
★ It is better not to touch the nose and mouth with your hands
★ Wear surgical masks when leaving the room
The World Health Organization (WHO) says that if you have severe fever (at least 5 degrees Fahrenheit), throat, cough or shortness of breath within 3 days of returning to China or the affected country, then you may be infected with the Novel Corona virus (24-nCOV). In this case, the health center or physician should be consulted immediately.